|1.||Stoering, Marla: 1 article (11/2015)|
|2.||Ackerman, Bruce H: 1 article (11/2015)|
|3.||Ross, Kerry M: 1 article (11/2015)|
|4.||Reigart, Cynthia L: 1 article (11/2015)|
|5.||Stair-Buchmann, Megan E: 1 article (11/2015)|
|6.||Patton, Mary Lou: 1 article (11/2015)|
|7.||Guilday, Robert E: 1 article (11/2015)|
|8.||Herder, Diane: 1 article (11/2015)|
|9.||Haith, Linwood R: 1 article (11/2015)|
|10.||Leas, Michelle L: 1 article (05/2014)|
05/01/1976 - "Experiments showed that as a local dressing for burns, non-laminated collagen sponge was significantly better than pigskin or xeroform. "
09/01/1995 - "Management of skin-grafted burn wounds with Xeroform and layers of dry coarse-mesh gauze dressing results in excellent graft take and minimal nursing time."
05/01/2014 - "This clinical study assessed the effectiveness of a new oxygen-diffusion dressing (OxyBand; Oxyband Technologies, St. Louis, MO) compared with standard Xeroform gauze dressings (Convidien, Mansfield, MA), in the care of skin-graft donor sites in burn patients. "
09/01/1995 - "We prospectively studied the efficacy of our standard dressing of one layer of Xeroform (Kendall Inc., Mansfield, Mass.), which consists of fine-mesh gauze impregnated with bismuth tribromophenate, applied to the STSG surface followed by layers of dry gauze dressings wrapped in Kerlix (Kendall Inc.); the entire dressings were left intact until postoperative day 5. We evaluated 142 STSGs on 100 patients, mean age 29.2 years (range 0.3 to 79 years), with burns of 0.5% to 60% total body surface area (mean 9.1%). "
06/01/1981 - "In 11 piglets with a burn wound, the most adherent dressing was collagen sponge(CS), followed by polyurethane sponge (PU), pigskin xenograph (PS), and xeroform. "
01/01/1998 - "The use of VWDS eliminated donor site pain and accelerated reepithelialization compared with Xeroform gauze. "
05/01/2014 - "Pain scores were lower (P < .01) at the OxyBand site compared with the Xeroform site at all time points during postoperative days 4 to 12. "
03/01/1995 - "Mean pain rating was 22.28 mm for Xeroform and 15.29 mm for SkinTemp. "
11/01/2015 - "Although patients complained of more pain with Xeroform, it demonstrated shorter healing times and better cosmetic outcomes. "
11/01/2015 - "Daily pain scores were higher with Xeroform (6.72 vs 5.68) and Aquacel Ag needed to be replaced more often (1.72 times vs 0.10 times). "
|3.||Wounds and Injuries (Trauma)
02/01/2011 - "Wounds in 19 control patients with type II diabetes were treated with a Xeroform gauze dressing. "
03/01/1999 - "Group 1 received our standard treatment--Xeroform gauze (Sherwood Medical, St Louis, Mo) and daily wound care. "
06/01/1981 - "Wound contraction was maximal with CS dressing (52%), followed by PU (44%), xeroform (32%), and PS (27%). "
07/01/1979 - "Four days of open wound management with Xeroform gauze between the skin and subcutaneous tissue is followed on the 5th day be removal of the Xerform and skin approximation with Steri-Strips. "
05/01/2014 - "Patients underwent harvesting of split-thickness skin grafts with one donor wound dressed with OxyBand and the other dressed in Xeroform gauze. "
01/01/1998 - "In contrast, there were two cases of suspected infection at the donor sites treated with Xeroform gauze. "
01/01/2008 - "One of these trials reported that infection rates were lower (9%) with a regimen that included cleansing with half strength hydrogen peroxide and application of Xeroform dressing when compared with other regimens with different cleansing and dressing regimens (rates >26%) but this may be a chance difference. "
09/01/2005 - "Results suggest that other factors outside the realm of this study may affect children's pin-site infection rate and that half-strength peroxide and Xeroform dressings were superior to soap-and-water cleansing. "
07/01/1991 - "No infections occurred in donor sites dressed with xeroform, but two developed in patients using Biobrane. "
12/01/2005 - "Our study assessed the potential effects of nineteen BDEs, five hydroxylated BDEs (OH-BDEs), one methoxylated BDE (CH(3)O-BDE), tetrabromobisphenol-A (TBBPA), its dibromopropane ether derivative (TBBPA-DBPE), and the brominated phenols/anisols 2,4,6-tribromophenol (TBP), 4-bromophenol (4BP) and 2,4,6-tribromoanisole (TBA) on the catalytic activity of the steroidogenic enzyme aromatase (CYP19) in H295R human adrenocortical carcinoma cells. "
|3.||Fibrin Tissue Adhesive (Fibrin Sealant)
|7.||Hydrogen Peroxide (Hydroperoxide)
|8.||Ethyl Ether (Ether)
|1.||Hydrocolloid Bandages (Duoderm)